Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Bo Xin, Jinglu Huang, Jin Lu, Jie Li, Xipeng Sun, Chunyan Li, Yan Huo, Jianping Zhang, Yonglong Han & Cheng Guo. (2022) Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (5)
Gilbert Badia Anugerah & Achmad Nizar Hidayanto. (2023) What Factors Contribute to the Acceptance of Artificial Intelligence on Healthcare Sector: A Systematic Review. What Factors Contribute to the Acceptance of Artificial Intelligence on Healthcare Sector: A Systematic Review.
Xiao Dong, Shu Xia, Shubo Du, Mao-Hua Zhu, Xing Lai, Shao Q. Yao, Hong-Zhuan Chen & Chao Fang. (2023) Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy. ACS Central Science 9:10, pages 1864-1893.
Crossref
Crossref
Trevor W. Stone & Richard O. Williams. (2023) Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends in Pharmacological Sciences 44:7, pages 442-456.
Crossref
Crossref
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon & Chan Kim. (2022) High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14:23, pages 5985.
Crossref
Crossref
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon & Chan Kim. (2022) Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Journal for ImmunoTherapy of Cancer 10:6, pages e004799.
Crossref
Crossref